A study led by the University of Oxford to test whether hydroxychloroquine or chloroquine can prevent Covid-19 among healthcare workers initiated enrolment of participants at the Aga Khan University on Wednesday. The selection for each will be at random, with neither the participants nor the administrators knowing who has received what. Laboratory experiments have shown hydroxychloroquine or chloroquine to kill the coronavirus, according to AKU. The COPCOV is the only non-vaccine Covid-19 prophylaxis study deemed urgent by the UK's NIHR Clinical Research Network. AKU doctors Farah Qamar, Faisal Mehmood, Noshin Nasir, Momin Qazi, Sonia Qureshi and AKU Clinical Trials Unit director Saeed Hamid are supporting the study in Pakistan.

Source: The Express Tribune October 29, 2020 04:07 UTC